Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2014 by University of Padova.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
University of Padova
ClinicalTrials.gov Identifier:
NCT00742690
First received: August 26, 2008
Last updated: October 11, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Publications: